ada standards of care 2025 obesity pharmacotherapy glp-1 Your Guide to the WHO Releases Guidelines on GLP-1

methods of use for treating different indications, including diabetes, weight loss, heart disease and others

Maybe we switch from subcutaneous therapy to oral

Mays safety headlines included: Concerns about psychiatric side effects (ScienceDirect) Risks for patients with asthma (American Lung Association) Ongoing issues around nutrient deficiencies and GI side effects (AJCN) What This Means for Your Practice: Enhance mental health screenings before and during treatment

She mentioned that while theyre not as restrictive as other compression leggings shes tried, they may not be warm enough for cold days

The FDA has reported 392 adverse events with compounded semaglutide and 215 with compounded tirzepatide, including multiple hospitalisations from dosing errors